RT15 mg

Retatrutide 15mg

Reta, also known as Retatrutide, is an investigational peptide studied for its interaction with GLP-1, GIP, and glucagon receptors at the cellular level. Research explores its effects on metabolic signaling, insulin sensitivity pathways, and energy regulation mechanisms in vitro.

$129.00 USD

Shipping calculated at checkout.

Research use only

All products sold on this website are for research and laboratory purposes only. They are not for human or animal use, including injection, ingestion, or any other form of administration. These products are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for legitimate laboratory research and not for human or animal consumption.

Purity Retatrutide 15mg

Certificate of Analysis

Third-party tested for 99% purity, ID, quantity.

RT15 contains retatrutide (LY3437943), a synthetic peptide investigated as a GLP-1, GIP, and glucagon receptor agonist in clinical research, with published studies describing significant weight reduction and metabolic endpoints in obesity and related metabolic disease models.

Body weight and appetite regulation research models
Glycemic control and insulin signaling pathway research
Liver fat and metabolic dysfunction related steatotic liver disease research models
Cardiometabolic marker and energy balance pathway studies

Retatrutide Structure

CAS #: 2381089-83-2

Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈

Molecular Weight: 4845.44 g/mol

PubChem ID: 474492335

Purity: ≥99%, third-party tested.
Batch / Lot: Provided on vial label and confirmed at delivery.
Certificate of Analysis (per batch): Provided at delivery for the shipped lot/batch.

Store in a cool, dry, dark place and minimize exposure to heat, moisture, light, and air. Avoid unnecessary temperature changes and reseal promptly after use. For full best practices and detailed guidance, read our Storage & Handling page.